Last reviewed · How we verify

NCT05874531

End-expiratory Occlusion Test and Prediction of Preload Dependence

Completed Last updated 25 September 2023
What this trial tests

trial testing End-expiratory occlusion test in Intensive Care Units in 60 participants. Completed in 15 September 2023.

Timeline
15 May 2023
Primary endpoint
15 August 2023
15 September 2023

Quick facts

Lead sponsorMongi Slim Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment60
Start date15 May 2023
Primary completion15 August 2023
Estimated completion15 September 2023
Sites1 location across Tunisia

Drugs / interventions tested

Conditions studied

Sponsor

Mongi Slim Hospital

Who can join

18 and older, any sex, with Intensive Care Units or Ultrasonography. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Three sets of measurements of hemodynamic parameters and sub-aortic VTI were performed: before and at the end of 15 seconds end-expiratory occlusion and after 250 mL saline administration over 10 minutes. Patients were considered responders to fluid loading after an increase in sub-aortic VTI of more than 10% following a volume expansion. SPSS was used for statistic study. A p \< 0.05 was considered significant. The investigators performed univariate and then multivariate analysis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of End-expiratory occlusion test

Trials testing the same drug.

Other recruiting trials for Intensive Care Units

Currently open trials in the same condition.

Other Mongi Slim Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05874531.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing